Discover Data,
Develop Insights, Deliver Value

It’s what we do best

Services

Premier services that lead to better, faster decisions, customized solutions, and successful partnerships.

Learn More

Data

In-house and commercially-available data to meet your needs.

Learn More

Publications

Over 1000 peer-reviewed publications in dozens of therapeutic areas!

Learn More

Publication

A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors

Exp Rev Hematol
Escobar M, Bullano M, Mokdad AG, et al. A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors. Exp Rev Hematol. 2023 Apr 28;1-8.

Read now
Blog

Spring 2023 Newsletter

Get the latest news, highlights and more about conferences, RWD, and evidence generation from The Authority in RWE.

Read now
Blog

FAQs: Real-World Questions, Answered.

Read now

Schedule Your
Consultation Today




    The amazing research collaboration between STATinMED and our team has already led to a comprehensive body of evidence to inform confident decision-making for many patients.

    Joint Partnership Alliance

    Real-World Evidence Executive

    The abstract has been accepted as a podium presentation at ISPOR! Many thanks to the team for all the hard work over the last several months!

    HEOR Executive

    global biopharmaceutical company

    The abstract has been accepted as a podium presentation at ISPOR! Many thanks to the team for all the hard work over the last several months!

    HEOR Executive

    global biopharmaceutical company

    Let’s give kudos to ourselves for everything we have accomplished together. Please share with STATinMED colleagues involved in the study–let them know our deep appreciation for all of them.

    Real-World Evidence Executive

    Joint Partnership Alliance

    On behalf of our study team, I would like to thank you all for your tremendous help on the study. Acceptance by Stroke is a watershed moment for the Real-World Data program.

    Real-World Evidence Executive, Joint Partnership Alliance

    two global biopharmaceutical companies